Collegium Pharmaceutical (COLL) PT Lowered to $26 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Collegium Reports Third Quarter Fiscal 2021 Results
November 4, 2021 4:02 PM EDT- Board of Directors Has Authorized $25 Million Accelerated Share Repurchase Program -
- Net Income of $8.0 Million and Adjusted EBITDA of $37.3 Million -
- Full-Year 2021 Guidance Updated -
- Conference Call Scheduled for Today at 4:30 p.m. ET -
STOUGHTON, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being... More
